If you have been reading about thymosin beta-4 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-03-04. Where a claim depends on a specific study, the study is described rather than over-claimed.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming is inconsistent across suppliers and publications |
| Reported sequence | Ac-LKKTETQ | Corresponds to residues 17-23 of the parent protein |
| Frequently cited registry number | 77591-33-4 | Associated with full-length thymosin beta-4 rather than the fragment |
| Common supplied form | Freeze-dried solid | Often presented as an acetate or trifluoroacetate salt |
| Regulatory treatment | Varies by country | Frequently handled as a research chemical; not broadly approved as a therapeutic |
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
=== Dementia === A 2020 Cochrane review found no evidence that melatonin helped sleep problems in people with moderate to severe dementia due to Alzheimer's disease. A 2019 review found that while melatonin may improve sleep in minimal cognitive impairment, after the onset of Alzheimer's disease it had little to no effect. Melatonin may, however, help with sundowning (increased confusion and restlessness at night) in people with dementia.
In chemistry, thermodynamics, and other chemical engineering, a steady state is a situation in which all state variables are constant in spite of ongoing processes that strive to change them. For an entire system to be at steady state, i.e. for all state variables of a system to be constant, there must be a flow through the system (compare mass balance). One of the simplest examples of such a system is the case of a bathtub with the tap open but without the bottom plug: after a certain time the water flows in and out at the same rate, so the water level (the state variable being Volume) stabilizes and the system is at steady state. Of course the Volume stabilizing inside the tub depends on the size of the tub, the diameter of the exit hole and the flowrate of water in. Since the tub can overflow, eventually a steady state can be reached where the water flowing in equals the overflow plus the water out through the drain. A steady state flow process requires conditions at all points in an apparatus remain constant as time changes. There must be no accumulation of mass or energy over the time period of interest. The same mass flow rate will remain constant in the flow path through each element of the system. Thermodynamic properties may vary from point to point, but will remain unchanged at any given point.
The term was originally coined by George Johnstone Stoney in 1891 as a tentative name for the basic unit of electrical charge (which had then yet to be discovered). For some years Thomson resisted using the word "electron" because he didn't like how some physicists talked of a "positive electron" that was supposed to be the elementary unit of positive charge just as the "negative electron" is the elementary unit of negative charge. Thomson preferred to stick with the word "corpuscle" which he strictly defined as negatively charged. He relented by 1914, using the word "electron" in his book The Atomic Theory. In 1920, Rutherford and his fellows agreed to call the nucleus of the hydrogen ion "proton", establishing a distinct name for the smallest known positively-charged particle of matter (that can exist independently anyway).
=== Pharmacokinetics === The brain-to-blood ratio of alprenolol in humans has been found to be 16:1. For comparison, the brain-to-blood ratio of the highly lipophilic propranolol was 15:1 to 26:1 and of the hydrophilic atenolol was 0.2:1.
Sources: en.wikipedia.org
== D == Dendrite A branched projection of a neuron that receives synaptic input from other neurons and transmits electrical signals toward the cell body. Dendritic spine A small, membranous protrusion from a neuron's dendrite that typically receives input from a single synapse of an axon. Spines are key sites for synaptic strength and plasticity. Depolarization A change in membrane potential that makes the interior of a neuron more positive relative to the outside, often initiating an action potential if a threshold is reached. Descending neuron A neuron that originates in the brain or brainstem and projects downward through the spinal cord to influence motor circuits and autonomic function. Descending neurons are critical for voluntary movement, postural control, and reflex modulation. Major descending pathways include the corticospinal, reticulospinal, rubrospinal, and vestibulospinal tracts. Developmental neuroscience A branch of neuroscience focused on how the nervous system develops from embryonic stages through adulthood, including neurogenesis, synaptogenesis, and pruning. Diffusion tensor imaging (DTI) A form of magnetic resonance imaging that maps the diffusion of water molecules in brain tissue to visualize white matter tracts and structural connectivity. Diencephalon A region of the forebrain that includes structures such as the thalamus and hypothalamus. It plays a role in sensory relay, autonomic function, and endocrine regulation.
Federalism has a long tradition in German history. Until the early 19th century, the majority of the territory that later became Germany was part of the Holy Roman Empire, which in 1796 was made up of more than 300 individual political entities subject to the Holy Roman Emperor in Vienna. The number of states was greatly reduced during the Napoleonic Wars (1796–1814), and the Empire itself was abolished in 1806. The Congress of Vienna, which restructured Europe after the wars, created the highly federalized 39-state German Confederation in 1815. The Confederation was dissolved after the Austro-Prussian War (1866) in which Prussia defeated the Austrian Empire and effectively excluded it from taking part in the eventual unification of Germany. Following the war, the states of northern and central Germany united under the leadership of the Kingdom of Prussia to form the federal North German Confederation. During the Franco-Prussian War (1870–1871), the four southern German states of Bavaria, Württemberg, Baden and Hesse-Darmstadt joined the North German Confederation, which was rechristened the German Empire with Prussia's victory. The Reichstag and Federal Council (Bundesrat) gave the Prussian king the title of German Emperor (as of 1 January 1871). With only relatively minor changes that did not affect its federalized nature, the North German Constitution became the imperial constitution. The new German Empire included 25 states (three of them free cities) plus the imperial territory of Alsace–Lorraine, which had been won from France in the war.
Christians are the next largest religious minority after Hindus, constituting 1.37% of the population. They are concentrated in Lahore District (5%) and Islamabad Capital Territory (over 4%). Karachi hosts a historic Roman Catholic community established by Goan and Tamil migrants during British colonial rule. Following Christianity, the Bahá'í Faith had 30,000 followers in 2008, followed by Sikhism, Buddhism, and Zoroastrianism, each with around 20,000 adherents in 2008, alongside a small Jain community.
Sources: en.wikipedia.org
The leading proposal involves sequestration of monomeric actin, which would alter cytoskeletal turnover and cell movement. The actin-binding motif shared with the parent protein is central to that idea. Direct confirmation in whole organisms remains limited.
Very few controlled human studies focus on the seven-residue sequence itself. Most clinical data concern the full-length protein in cardiac or ophthalmic settings. Conclusions drawn for one form should not be assumed to transfer to the other.
Detection normally relies on reversed-phase liquid chromatography paired with mass spectrometry. Chromatographic retention time establishes the expected elution window, and the mass spectrum confirms the molecular ion. Immunoassays exist but can cross-react with related peptides.
The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.